NPPB and myocardial infarction: The primary outcomes were mortality, major adverse cardiovascular outcomes, heart failure, recurrent myocardial infarction, and improvement in left ventricle ejection fraction (LVEF) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentration post MI, while a number of rehospitalizations and hypotension were the secondary outcomes.